Elevance Health, Inc. (ELV) on GreekSoup https://greeksoup.ai/stocks/us/elv/ Every dated entry in the public record on Elevance Health, Inc.: results, filings, insider trades and the rest, from the filings, the last 90 days. en Wed, 23 Sep 2026 00:00:00 +0000 Elevance Health, Inc. filed 8-K: regulation fd disclosurehttps://greeksoup.ai/stocks/us/elv/filings/us:ELV:filing:2026-09-10:af10fb111aThu, 10 Sep 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> Elevance Health, Inc.: short interest 5,485,788 shares at the 31 August 2026 settlement, 6.56 days to coverhttps://greeksoup.ai/stocks/us/elv/short-interest/us:ELV:short-interest:2026-08-31:ea2fc5f323Mon, 31 Aug 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Elevance Health, Inc.: short interest 5,405,640 shares at the 14 August 2026 settlement, 5.67 days to coverhttps://greeksoup.ai/stocks/us/elv/short-interest/us:ELV:short-interest:2026-08-14:a49759482fFri, 14 Aug 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Elevance Health, Inc.: short interest 5,586,082 shares at the 31 July 2026 settlement, 3.93 days to coverhttps://greeksoup.ai/stocks/us/elv/short-interest/us:ELV:short-interest:2026-07-31:8713b46d3fFri, 31 Jul 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Elevance Health, Inc.: Peru Ramiro G (Director) bought 1,000 shares at $366.05 on 17 July 2026, $366,050https://greeksoup.ai/stocks/us/elv/insiders/us:ELV:insider:2026-07-17:c6fdb50265Fri, 17 Jul 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Elevance Health, Inc.: Boudreaux Gail (President and CEO) bought 680 shares at $366.41 on 17 July 2026, $249,159https://greeksoup.ai/stocks/us/elv/insiders/us:ELV:insider:2026-07-17:f1b858d314Fri, 17 Jul 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Elevance Health, Inc.: Boudreaux Gail (President and CEO) bought 2,045 shares at $368.25 on 17 July 2026, $753,071https://greeksoup.ai/stocks/us/elv/insiders/us:ELV:insider:2026-07-17:e3d5ad7ac8Fri, 17 Jul 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Elevance Health, Inc. Q2 FY2026 results: revenue $50.5 billion, net income $1.5 billionhttps://greeksoup.ai/stocks/us/elv/results/fy2026-q2/us:ELV:result:2026-07-15:0bf7e33b3fWed, 15 Jul 2026 00:00:00 +0000ResultsResults. The filing. The page on GreekSoup.

]]> Elevance Health, Inc. filed 10-Q: 10-qhttps://greeksoup.ai/stocks/us/elv/filings/us:ELV:filing:2026-07-15:6687dc54bdWed, 15 Jul 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> Elevance Health, Inc. filed 8-K: results of operationshttps://greeksoup.ai/stocks/us/elv/filings/us:ELV:filing:2026-07-15:77ee5c802aWed, 15 Jul 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> Elevance Health, Inc.: short interest 6,025,314 shares at the 15 July 2026 settlement, 3.52 days to coverhttps://greeksoup.ai/stocks/us/elv/short-interest/us:ELV:short-interest:2026-07-15:86f6285f78Wed, 15 Jul 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Elevance Health, Inc.: Form 144, CLARK R KERRY plans to sell 1,500 shares worth $629,865 around 7 July 2026https://greeksoup.ai/stocks/us/elv/planned-sales/us:ELV:planned-sale:2026-07-07:63be623f3cTue, 07 Jul 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> Elevance Health, Inc.: short interest 6,009,556 shares at the 30 June 2026 settlement, 3.27 days to coverhttps://greeksoup.ai/stocks/us/elv/short-interest/us:ELV:short-interest:2026-06-30:cbdda9877fTue, 30 Jun 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]>